J Korean Soc Radiol.  2012 Apr;66(4):375-384. 10.3348/jksr.2012.66.4.375.

Reversible Restricted Diffusion in the Corpus Callosum in Various Pediatric Diseases

Affiliations
  • 1Department of Radiology, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea. hshong@schmc.ac.kr
  • 2Department of Radiology, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Korea.

Abstract

PURPOSE
To evaluate the reversible restricted diffusion in the corpus callosum in pediatric patients with clinical findings, and to discuss the possible pathogenesis of these lesions.
MATERIALS AND METHODS
Between 2007 and 2011, seven children with reversible signal abnormalities in the corpus callosum were identified and retrospectively reviewed.
RESULTS
Diseases and conditions associated with lesions included: trauma (n = 3), neonatal seizure (n = 1), clinically suspected mild encephalopathy (n = 1), multiple sclerosis (n = 1), and seizure with subdural hygroma (n = 1). The callosal lesions were located in the splenium and the genu (n = 2), the splenium and the body (n = 1), and the splenium only (n = 4). The shape of the lesions was round-to-ovoid (n = 4) or linear (n = 3). Follow-up MRI scans showed completely resolved (n = 6) or persistent (n = 1) signal abnormalities on diffusion-weighted imaging as well as apparent diffusion coefficient mapping. Clinical outcomes were good in six of the patents but poor in the seventh.
CONCLUSION
Reversible restricted diffusion in the corpus callosum can develop in various diseases. Knowledge of the MRI findings and associated diseases might be helpful in predicting patients' conditions and clinical outcomes.


MeSH Terms

Child
Corpus Callosum
Diffuse Axonal Injury
Diffusion
Follow-Up Studies
Humans
Magnetic Resonance Imaging
Multiple Sclerosis
Retrospective Studies
Seizures
Subdural Effusion

Figure

  • Fig. 1 A 4-year-old boy with drowsy mentality caused by motorcar accident (case 1). Initial MRI (A-C) shows well-defined, tiny, ovoid-shaped bright SI lesions (arrows) on DWI (A) in the genu and the splenium, dark SI (arrow) on an ADC map (B) in the genu of the corpus callosum. T2-WI (C) shows high SI lesions in the genu and the splenium (arrows) and crescentic subdural hygroma in the left frontal region (arrowhead). Multiple hemorrhagic foci were observed in the left cerebellum and pons, on gradient echo imaging, and cerebral contusions were observed in the right frontal and left parietal lobes (not shown). Follow-up MRI (D-F) after 6 months shows complete resolution of signal abnormalities on all sequences. Note.-ADC = apparent diffusion coefficient, DWI = diffusion-weighted imaging, SI = signal intensity, T2-WI = T2-weighted image

  • Fig. 2 A 14-year-old girl with stuporous mentality following a motorcycle traffic accident (case 3). Initial MRI (A-C) shows multifocal nodular high SI lesions (arrow) on DWI (A) and low SI (arrow) on an ADC map (B) in the splenium and the body of the corpus callosum. FLAIR imaging (C) shows high SI lesions in the splenium and the body (arrow), with hemorrhagic contusion in the left frontotemporal cortex (arrowhead). Follow-up MRI (D-F) after 17 months shows complete resolution of signal abnormalities on all sequences. Note.-ADC = apparent diffusion coefficient, DWI = diffusion-weighted imaging, FLAIR = fluid-attenuated inversion-recovery, SI = signal intensity

  • Fig. 3 A male infant with clonic seizures (case 4). Initial MRI (A-C) shows bilateral linear high SI lesions (arrows) on DWI (A) and low SI (arrows) on an ADC map (B) in the splenium of the corpus callosum. On T2-WI (C), the signal abnormality is not obvious. Additionally, crescentic subdural hemorrhage was observed along the tentorium and interhemispheric fissure (not shown). Follow-up MRI (D-F) after 17 days (20 days of age), shows resolution of signal abnormalities on DWI (D) and an ADC map (E). Follow-up T2-WI (F) also shows no signal abnormality. Note.-ADC = apparent diffusion coefficient, DWI = diffusion-weighted imaging, SI = signal intensity, T2-WI = T2-weighted image

  • Fig. 4 A 14-year-old boy with headache and fever (case 5). Initial MRI (A-C) shows ovoid high SI lesion (arrow) on DWI (A) and iso-SI (arrow) on an ADC map (B) in the central portion of the splenium. T2-WI (C) shows well-defined, ovoid, high SI (arrow) in the splenium of the corpus callosum. Follow-up MRI (D-F), after 1 month, shows resolution of signal abnormalities on all sequences. Note.-ADC = apparent diffusion coefficient, DWI = diffusion-weighted imaging, SI = signal intensity, T2-WI = T2-weighted image

  • Fig. 5 A 19-year-old man with a history of multiple sclerosis (case 6) experienced nausea and vomiting. Initial MRI (A-C) shows focal, nodular, bright SI lesion (arrow) on DWI (A) and dark SI (arrow) on an ADC map (B) in the right lateral aspect of the splenium. T2-WI (C) shows high SI lesion in the splenium (white arrow) and other multifocal nodular high SI lesions in both thalami, right caudate nucleus, and periventricular white matter of the left parietal lobe (black arrows), suggesting multiple sclerosis. Follow-up MRI (D-F), after 17 months, shows resolution of signal abnormalities in the splenium on all sequences. Note.-ADC = apparent diffusion coefficient, DWI = diffusion-weighted imaging, SI = signal intensity, T2-WI = T2-weighted image

  • Fig. 6 A 3-month-old girl with episodes of seizures (case 7). Initial MRI (A-C) shows bilateral linear bright SI lesions (arrows) on DWI (A) and low SI (arrows) on an ADC map (B) in the splenium of the corpus callosum, crossing the midline. Ill-defined high SI lesions on DWI, with subtle cortical sulcal effacement, are seen in both occipital lobes (black arrows) without low SI on ADC map, suggesting vasogenic edema. FLAIR imaging (C) shows high SI in the splenium (arrows) and crescentic subdural hygroma in both frontotemporoparietal regions (asterisk). Subdural hygroma on conventional T1-WI and T2-WI (not shown) was well-depicted, showing iso-SI to the cerebrospinal fluid. After 1 month, the girl revisited our hospital for general weakness. Follow-up MRI (D-F) shows that the bilateral linear lesions in the splenium are persistent (arrows) on DWI (D) and an ADC map (E). FLAIR imaging (F) shows the amount of subdural hygroma in both frontotemporo-parietal regions has increased, with complicated hemorrhage (asterisk). A burr-hole craniotomy was performed for drainage of the subdural hygroma. Note.-ADC = apparent diffusion coefficient, DWI = diffusion-weighted imaging, FLAIR = fluid-attenuated inversion-recovery, SI = signal intensity, T1-WI = T1-weighted image, T2-WI = T2-weighted image


Reference

1. Matsukawa H, Shinoda M, Fujii M, Takahashi O, Yamamoto D, Murakata A, et al. Genu of corpus callosum in diffuse axonal injury induces a worse 1-year outcome in patients with traumatic brain injury. Acta Neurochir (Wien). 2011; 153:1687–1693. discussion 1693-1694
2. Kim SS, Chang KH, Kim ST, Suh DC, Cheon JE, Jeong SW, et al. Focal lesion in the splenium of the corpus callosum in epileptic patients: antiepileptic drug toxicity? AJNR Am J Neuroradiol. 1999; 20:125–129.
3. Prilipko O, Delavelle J, Lazeyras F, Seeck M. Reversible cytotoxic edema in the splenium of the corpus callosum related to antiepileptic treatment: report of two cases and literature review. Epilepsia. 2005; 46:1633–1636.
4. Mirsattari SM, Lee DH, Jones MW, Blume WT. Transient lesion in the splenium of the corpus callosum in an epileptic patient. Neurology. 2003; 60:1838–1841.
5. Matsubara K, Kodera M, Nigami H, Yura K, Fukaya T. Reversible splenial lesion in influenza virus encephalopathy. Pediatr Neurol. 2007; 37:431–434.
6. Fukuda S, Kishi K, Yasuda K, Sejima H, Yamaguchi S. Rotavirus-associated encephalopathy with a reversible splenial lesion. Pediatr Neurol. 2009; 40:131–133.
7. Ogura H, Takaoka M, Kishi M, Kimoto M, Shimazu T, Yoshioka T, et al. Reversible MR findings of hemolytic uremic syndrome with mild encephalopathy. AJNR Am J Neuroradiol. 1998; 19:1144–1145.
8. Kim JH, Choi JY, Koh SB, Lee Y. Reversible splenial abnormality in hypoglycemic encephalopathy. Neuroradiology. 2007; 49:217–222.
9. Bourekas EC, Varakis K, Bruns D, Christoforidis GA, Baujan M, Slone HW, et al. Lesions of the corpus callosum: MR imaging and differential considerations in adults and children. AJR Am J Roentgenol. 2002; 179:251–257.
10. Grühbaum B, Salzer H, Nasel C, Lernbass I. Reversible cytotoxic oedema in the splenium of the corpus callosum related to tetracycline therapy. Pediatr Radiol. 2010; 40:1693–1695.
11. Tada H, Takanashi J, Barkovich AJ, Oba H, Maeda M, Tsukahara H, et al. Clinically mild encephalitis/encephalopathy with a reversible splenial lesion. Neurology. 2004; 63:1854–1858.
12. Karaarslan E, Arslan A. Diffusion weighted MR imaging in non-infarct lesions of the brain. Eur J Radiol. 2008; 65:402–416.
13. Takanashi J, Maeda M, Hayashi M. Neonate showing reversible splenial lesion. Arch Neurol. 2005; 62:1481–1482. author reply 1482
14. Kubota T, Kidokoro H, Ito M, Oe H, Hattori T, Kato Y, et al. Diffusion-weighted imaging abnormalities in the corpus callosum after neonatal seizure: a case report. Brain Dev. 2008; 30:215–217.
15. Takanashi J, Hirasawa K, Tada H. Reversible restricted diffusion of entire corpus callosum. J Neurol Sci. 2006; 247:101–104.
16. Sigal T, Shmuel M, Mark D, Gil H, Anat A. Diffusion tensor imaging of corpus callosum integrity in multiple sclerosis: correlation with disease variables. J Neuroimaging. 2012; 22:33–37.
17. Simon JH, Holtås SL, Schiffer RB, Rudick RA, Herndon RM, Kido DK, et al. Corpus callosum and subcallosal-periventricular lesions in multiple sclerosis: detection with MR. Radiology. 1986; 160:363–367.
18. Maeda M, Tsukahara H, Terada H, Nakaji S, Nakamura H, Oba H, et al. Reversible splenial lesion with restricted diffusion in a wide spectrum of diseases and conditions. J Neuroradiol. 2006; 33:229–236.
Full Text Links
  • JKSR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr